Nevertheless, using nanopore sequencing technology, we unexpectedly found that what are usually rare and potentially antagonistic isoforms of BARD1 transcription are in fact expressed at relatively high levels in melanoma and melanocytes. This evidence concerns the gene BARD1 and melanoma.